Skylands Capital’s Core Laboratories CLB Stock Holding History

Skylands Capital’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-5,000	Closed	-$992K	–	251
2014 Q1	$992K	Buy	5,000 +1,000	+25%	+$189K	0.1%	145
2013 Q4	$764K	Sell	4,000 -1,000	-20%	-$186K	0.08%	151
2013 Q3	$846K	Hold	5,000	–	–	0.09%	159
2013 Q2	$758K	Buy	+5,000	New	+$708K	0.09%	159

Other funds holding CLB

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Skylands Capital's CLB Position: Q2 2014 in Review

Skylands Capital sold out of Core Laboratories (CLB) in Q2 2014, closing a stake of 5,000 shares — an estimated $992K sold.

Skylands Capital first reported a position in CLB in Q2 2013 and held it in 4 quarters. The position peaked at $992K in Q1 2014. 346 funds tracked by Wall St. Rank hold CLB as of Q2 2014.

Skylands Capital reported no remaining Core Laboratories position as of Q2 2014 after selling out during the quarter.
Skylands Capital sold 5,000 Core Laboratories shares in Q2 2014, an estimated $992K.
Skylands Capital first reported a position in Core Laboratories in Q2 2013 and held it in 4 quarters.
Skylands Capital's Core Laboratories position peaked at $992K in Q1 2014.
346 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2014.

Based on Skylands Capital's 13F filing for Q2 2014, filed 22 Jul 2014.